Sanofi (SNY), Aeras and Statens Serum Institu Announce Results from Innovative Phase 2 Tuberculosis Vaccine Trial

 Sanofi (SNY), Aeras and Statens Serum Institu Announce Results from Innovative Phase 2 Tuberculosis Vaccine Trial
  1. Sanofi (SNY), Aeras and Statens Serum Institu Announce Results from Innovative Phase 2 Tuberculosis Vaccine Trial  StreetInsider.com
  2. TB vaccine trial results offer potential for BCG Revaccination, hope for subunit vaccines  Science Codex
  3. Two new vaccines show promise in preventing TB  THE WEEKFull coverage

Read More ...
Sanofi (SNY), Aeras and Statens Serum Institu Announce Results from Innovative Phase 2 Tuberculosis Vaccine Trial published February 20, 2018 at 06:07PM. Original Source Link : https://www.streetinsider.com/FDA/Sanofi+%28SNY%29%2C+Aeras+and+Statens+Serum+Institu+Announce+Results+from+Innovative+Phase+2+Tuberculosis+Vaccine+Trial/13835811.html
loading...

Related Posts :

0 Response to "Sanofi (SNY), Aeras and Statens Serum Institu Announce Results from Innovative Phase 2 Tuberculosis Vaccine Trial"

Posting Komentar